bpc 157 clinical evidence randomized trial humans BPC-157 for ACL recovery: hype vs. science | Adam C. Cady MHS, ATC, CSCS, PA-C posted on the topic If BPC-157 worked as well
Description
Food and Drug Administration (FDA) for human therapeutic use
Its benefits include: Inhibiting pro-inflammatory cytokines, which is beneficial for Crohns disease, ulcerative colitis, and autoimmune disorders
This makes it appealing in both medical and cosmetic contexts
Doses will be available for older children and adults who meet the restricted FDA eligibility conditions
